Cargando…
Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
Bladder cancer (BC) is a common urologic tumor with a high recurrence rate. Cuproptosis and long noncoding RNAs (lncRNAs) have demonstrated essential roles in the tumorigenesis of many malignancies. Nevertheless, the prognostic value of cuproptosis-related lncRNA (CRLs) in BC is still unclear. The p...
Autores principales: | Li, Hanrong, Jiang, Huiming, Huang, Zhicheng, Chen, Zhilin, Chen, Nanhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496989/ https://www.ncbi.nlm.nih.gov/pubmed/37616061 http://dx.doi.org/10.18632/aging.204972 |
Ejemplares similares
-
Prognostic Value of an m(5)C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma
por: Li, Hanrong, et al.
Publicado: (2021) -
Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023) -
Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023) -
Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
por: Chen, Jia, et al.
Publicado: (2022) -
A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)